Inventor · disambiguated record
Jo-Anne Hongo
Also filed as: HONGO JO-ANNE · HONGO JO-ANNE S
29 granted patents·26 pending applications·366 citations·filing 2001–2022
96Inventor score
Top patents by PatentIndex Score
55 records- 0198US7615383B2Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodiesGENENTECH INC·Filed 2006·Granted Nov 10, 2009·99 cites·19 claims
- 0297US7384632B2Agonist anti-trk-C monoclonal antibodiesGENENTECH INC·Filed 2001·Granted Jun 10, 2008·86 cites·2 claims
- 0395US8617559B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Dec 31, 2013·19 cites·34 claims
- 0494US8362213B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2010·Granted Jan 29, 2013·28 cites·53 claims
- 0592US8466260B2Anti-FcRH5 antibodies and immunoconjugates and methods of useELKINS KRISTI·Filed 2010·Granted Jun 18, 2013·21 cites·49 claims
- 0691US9360484B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Jun 7, 2016·7 cites·20 claims
- 0790US7858330B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Granted Dec 28, 2010·15 cites·20 claims
- 0889US7888478B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2005·Granted Feb 15, 2011·15 cites·92 claims
- 0985US9017951B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Apr 28, 2015·7 cites·1 claims
- 1085US8388973B2Compositions and methods for the treatment of tumor of hematopoietic originCHANG WESLEY·Filed 2010·Granted Mar 5, 2013·7 cites·58 claims
- 1185US7285382B2Compositions and methods for treatment of cancerGENENTECH INC·Filed 2001·Granted Oct 23, 2007·17 cites·3 claims
- 1284US7982015B2Compositions and methods for treatment of cancerGENENTECH INC·Filed 2005·Granted Jul 19, 2011·6 cites·22 claims
- 1384US7691566B2Compositions and methods for treatment of cancerGENENTECH INC·Filed 2006·Granted Apr 6, 2010·5 cites·6 claims
- 1482US9632091B2Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2015·Granted Apr 25, 2017·3 cites·17 claims
- 1582US9175089B2Anti-LGR5 antibodies and immunoconjugatesGENENTECH INC·Filed 2013·Granted Nov 3, 2015·5 cites·31 claims
- 1679US8398976B2Antibodies to EGFL7 and methods for their useYE WEILAN·Filed 2011·Granted Mar 19, 2013·4 cites·57 claims
- 1778US7799899B2Compositions and methods relating to STOP-1GENENTECH INC·Filed 2004·Granted Sep 21, 2010·14 cites·19 claims
- 1877US10435471B2Anti-FcRH5 antibodiesGENENTECH INC·Filed 2014·Granted Oct 8, 2019·3 cites·49 claims
- 1974US7572447B2Methods and compositions for selective modulation of vascularizationGENENTECH INC·Filed 2008·Granted Aug 11, 2009·2 cites·9 claims
- 2074US2023096941A1Anti-fcrh5 antibodiesGENENTECH INC·Filed 2022·Application pending·0 cites
- 2171US7407660B2Methods and compositions for selective modulation of vascularizationGENENTECH INC·Filed 2004·Granted Aug 5, 2008·2 cites·3 claims
- 2270US11352431B2Anti-FCRH5 antibodiesGENENTECH INC·Filed 2019·Granted Jun 7, 2022·0 cites·20 claims
- 2367US2010003261A1agonist anti-trk-c monoclonal antibodiesDEVAUX BRIGITTE·Filed 2009·Application pending·0 cites
- 2465US8691222B2NLRR-1 antagonists and uses thereofHAZEN MEREDITH·Filed 2008·Granted Apr 8, 2014·1 cites·16 claims
- 2564US2020199208A1Anti rspo antibodies and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2662US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 2762US2009297512A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2009·Application pending·0 cites
- 2857US2015147333A1Anti-rspo antibodies and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2957US2010203041A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2007·Application pending·0 cites
- 3056US2007031437A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2006·Application pending·0 cites
- 3156US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 3255US8563695B2Antibodies that bind β2HONGO JO-ANNE·Filed 2008·Granted Oct 22, 2013·0 cites·18 claims
- 3355US2012045443A1Agonist anti-trk-c monoclonal antibodiesDEVAUX BRIGITTE·Filed 2011·Application pending·0 cites
- 3454US9139659B2Idiotypic antibodies and uses thereofGENENTECH INC·Filed 2013·Granted Sep 22, 2015·0 cites·21 claims
- 3554US2005226869A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2004·Application pending·0 cites
- 3654US2013129735A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2013·Application pending·0 cites
- 3754US2015376265A1Antibody compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3853US2018312579A1Anti rspo antibodies and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 3952US9580514B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted Feb 28, 2017·0 cites·16 claims
- 4051US8993249B2Anti-neuropilin antibodies and methods of useGENENTECH INC·Filed 2013·Granted Mar 31, 2015·0 cites·8 claims
- 4149US2013058960A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2012·Application pending·0 cites
- 4249US2011206658A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 4348US2014328849A1Anti-crth2 antibodies and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4448US2011070243A1Compositions and methods for the treatment of tumor of hematopoieticCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 4547US8790646B2Compositions and methods for modulating vascular developmentFILVAROFF ELLEN·Filed 2010·Granted Jul 29, 2014·0 cites·18 claims
- 4646US11279762B2Idiotypic antibodies against anti-PD-L1 antibodies and uses thereofGENENTECH INC·Filed 2019·Granted Mar 22, 2022·0 cites·29 claims
- 4745US2007207142A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Application pending·0 cites
- 4845US2017129963A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2016·Application pending·0 cites
- 4943US2013143237A1Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2012·Application pending·0 cites
- 5042US2016102146A1Anti-lgr5 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jo-Anne Hongo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →